Publication date: Oct 08, 2019
Noninvasive transcranial magnetic stimulation (TMS) may help improve cognitive performance in patients with Parkinson disease (PD) and mild cognitive impairment, according to a recent study.
Noninvasive transcranial magnetic stimulation (TMS) may help improve cognitive performance in patients with Parkinson disease (PD) and mild cognitive impairment, according to a recent study The preliminary findings from this study with 28 patients suggest that the intervention might improve overall cognitive performance in patients with PD with mild cognitive impairment for as long as 1 month. PD is the second most frequent neurodegenerative disease, with symptoms consisting of motor deficits caused by the loss of dopaminergic neurons in the substantia nigra pars compacta.
Two studies of TMS previous transcranial magnetic stimulation studies over the left DLPFC showed short-term improvement in cognitive performance and focused on specific task. The researchers in this study used intermittent theta burst stimulation (iTBS) over the left DLPFC, which another study reported is best suited for enhancing executive function in patients with medication-resistant depression.
|disease||MESH||Mild Cognitive Impairment|
- Exercise increases caudate dopamine release and ventral striatal activation in Parkinson’s disease.
- Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson’s Disease
- High Frequency and Intensive Prevention Program